Aceruloplasminemia: An inherited neurodegenerative disease with impairment of iron homeostasis

Annals of the New York Academy of Sciences

Volumn 1012, Issue , 2004, Pages 299-305

  Xu, Xueying ^a   Pin, Sokhon ^a   Gathinji, Muraya ^a   Fuchs, Ralph ^a   Harris, Z Leah ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Aceruloplasminemia; Ceruloplasmin; Fet3; Homeostasis; Iron

Indexed keywords

BACTERIAL PROTEIN; CERULOPLASMIN; COPPER; CUPROUS OXIDASE; FERRITIN; FET3 PROTEIN; IRON; TRANSFERRIN; UNCLASSIFIED DRUG;

ACERULOPLASMINEMIA; ADULT; ANEMIA; AUTOSOMAL RECESSIVE DISORDER; BASAL GANGLION; BLEPHAROSPASM; BRAIN; BRAIN SPONGIOSIS; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; CERULOPLASMIN GENE; CLINICAL FEATURE; COPPER METABOLISM; DEGENERATIVE DISEASE; DIABETES MELLITUS; FAMILIAL ACERULOPLASMIN DEFICIENCY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE MUTATION; GLIOSIS; HEMOSIDEROSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; NERVE CELL DEGENERATION; NERVE DEGENERATION; NERVE INJURY; NEUROPATHOLOGY; ONSET AGE; OXIDATIVE STRESS; PANCREAS; PARKINSON DISEASE; PATHOGENESIS; RETINA; RETINA DEGENERATION; REVIEW; SACCHAROMYCES CEREVISIAE; SUBSTANTIA NIGRA; TRANSFERRIN BLOOD LEVEL;

BACTERIA (MICROORGANISMS); SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 1842504248     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1306.024     Document Type: Review

References (30)

1. MIYAJIMA, H., Y. NISHIMURA, K. MIZOGUCHI et al. 1987. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37: 761-767.
2. HARRIS, Z.L., Y. TAKAHASHI, H. MIYAJIMA et al. 1995. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 92: 2539-2543.
3. DAIMON, M., T. KATO, T. KAWANAMI et al. 1995. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem. Biophys. Res. Commun. 217: 89-95.
4. HARRIS, Z.L., M.D. MIGAS, A.E. HUGHES et al. 1996. Familial dementia due to a frameshift mutation in the caeruloplasmin gene. Q. J. Med. 89: 355-359.
5. OKAMOTO, N., S. WADA, T. OGA et al. 1996. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum. Genet. 97: 755-778.
6. YOSHIDA, K., K. FURIHATA, S. TAKEDA et al. 1995. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9: 267-272.
7. HELLMAN, N.E., S. KONO, H. MIYAJIMA & J.D. GITLIN. 2002. Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277: 1375-1380.
8. HELLMAN, N.E., S. KONO, G.M. MANCINI et al. 2002. Mechanisms of copper incorporation into human ceruloplasmin. J. Biol. Chem. 277: 46632-46638.
9. MIYAJIMA, H., S. KONO, Y. TAKAHASHI et al. 2001. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 57: 2205-2210.
10. KLOMP, L.W.J. & J.D. GITLIN. 1996. Expression of the ceruloplasmin gene in the human retina and brain: implications for the pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5: 1989-1996.
11. PATEL, B.N. & S. DAVID. 1997. A novel glycophosphatidylinositol- anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272: 20185-20190.
12. SALZER, J.L., L. LOVEJOY, M.C. LINDER & C. ROSEN. 1998. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J. Neurosci. Res. 54: 147-157.
13. FORTNA, R.R., H.A. WATSON & S.E. NYQUIST. 1999. Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed in Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol. Reprod. 61: 1042-1049.
14. BROWN, M.A., L.M. STENBERG & A.G. MAUK. 2002. Identification of catalytically important amino acids in human ceruloplasmin by site-directed mutagenesis. FEBS Lett. 520: 8-12.
15. INOUE, K., T. AKAIKE, Y. MIYAMOTO et al. 1999. Nitrosothiol formation catalyzed by ceruloplasmin: implication for cytoprotective mechanism in vivo. J. Biol. Chem. 274: 27069-27075.
16. LEE, G.R., S. NACHT, J.N. LUKENS & G.E. CARTWRIGHT. 1968. Iron metabolism in copper-deficient swine. J. Clin. Invest. 47: 2058-2069.
17. ROESER, H.P., G.R. LEE, S. NACHT & G.E. CARTWRIGHT. 1970. The role of ceruloplasmin in iron metabolism. J. Clin. Invest. 49: 2408-2417.
18. OSAKI, S., D. JOHNSON & E. FRIEDEN. 1966. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241: 2746-2757.
19. OSAKI, S., D.A. JOHNSON & E. FRIEDEN. 1971. The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase. J. Biol. Chem. 246: 3018-3023.
20. WESSLING-RESNICK, M. 2000. Iron transport. Annu. Rev. Nutr. 20: 129-151.
21. HARRIS, Z.L., A.P. DURLEY, T.K. MAN & J.D. GITLIN. 1999. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 96: 10812-10817.
22. PATEL, B.N., R.J. DUNN, S.Y. JEONG et al. 2002. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22: 6578-6586.
23. MIYAJIMA, H., Y. TAKAHASHI, M. SERIZAWA et al. 1996. Increased plasma lipid peroxidation in patients with aceruloplasminemia. Free Radical Biol. Med. 20: 757-760.
24. YOSHIDA, K., K. KANEKO, H. MIYAJIMA et al. 2000. Increased lipid peroxidation in the brains of aceruloplasminemic patients. J. Neurol. Sci. 175: 91-95.
25. KOHNO, S., H. MIYAJIMA, Y. TAKAHASHI et al. 2000. Defective electron transfer in complexes I and IV in patients with aceruloplasminemia. J. Neurol. Sci. 182: 57-60.
26. KANEKO, K., A. NAKAMURA, K. YOSHIDA et al. 2002. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radical Res. 36: 303-306.
27. MIYAJIMA, H., J. ADACHI, S. KOHNO et al. 2001. Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminemia patients. Q. J. Med. 94: 417-422.
28. MIYAJIMA, H., S. KONO, Y. TAKAHASHI & M. SUGIMOTO. 2002. Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemic brains. Blood Cells Mol. Dis. 29: 433-438.
29. MEYER, L.A., A.P. DURLEY, J.R. PROHASKA & Z.L. HARRIS. 2001. Copper transport and metabolism are normal in aceruloplasminemic mice. J. Biol. Chem. 276: 36857-36861.
30. 1+ oxidation modulate copper toxicity in Saccharomyces cerevisiae. J. Biol. Chem. 278: 50309-50315.